Research for a life without cancer
At the DKFZ, we want to ensure that fewer people develop cancer, that cancer can be cured or treated so effectively that those affected can live with the disease and grow old with a good quality of life.
About DKFZ
Latest from DKFZ
The 2026 Meyenburg Prize goes to bioinformatician and systems biologist Aviv Regev, head of research at the biotech company Genentech in San Francisco, USA. The scientist is considered a pioneer of single-cell genomics, a method that allows for the high-resolution measurement and analysis of gene activity in individual cells—a field of research that has fundamentally transformed biomedicine. The award, which comes with a prize of 50,000 euros, was presented on July 28 at a symposium marking the 50th anniversary of the Meyenburg Foundation at the German Cancer Research Center (DKFZ).
Our research opens doors in the fight against cancer
Do you have questions on the topic of cancer?
Let us advise you!
Doctors from the Cancer Information Service answer your questions every day. Find out more now for free!
